News & Resources

SEC Filings

<< Back
Form 8-K
OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 02/24/2017
Document Outline
Entire Document (594.5 KB)
Subdocument 1 - 8-K - FORM 8-K
Page 1 - UNITED STATES
Page 2 - Item 1.01 Entry into a Material Definitive Agreement.
Page 3 - SIGNATURES
Subdocument 2 - EX-4.1 - EX-4.1
Page 1 - Exhibit 4.1
Page 2 - Table of Contents
Page 3 - Table of Contents
Page 4 - Table of Contents
Page 5 - Table of Contents
Page 6 - Table of Contents
Page 7 - Company
Page 8 - Capital Stock
Page 9 - Ex-Dividend Date
Page 10 - Global Note
Page 11 - Officer s Certificate
Page 12 - Rule 144
Page 13 - Uniform Commercial Code
Page 14 - Rules of Construction
Page 15 - or
Page 16 - provided
Page 17 - Depositary
Page 18 - Registrar
Page 19 - Holder Lists
Page 20 - Transfer Restrictions.
Page 21 - Legends on the Common Stock.
Page 22 - Replacement Notes
Page 23 - provided
Page 24 - Persons Deemed Owners
Page 25 - Restrictions on Transfer of a Certificated Note for a Beneficial Interest in a Global Note.
Page 26 - N/A
Page 27 - CUSIP and ISIN Numbers
Page 28 - Fundamental Change Purchase Date
Page 29 - Fundamental Change Purchase Notice
Page 30 - Effect of Fundamental Change Purchase Notice
Page 31 - Deposit of Fundamental Change Purchase Price.
Page 32 - Repayment to the Company
Page 33 - Redemption Notice
Page 34 - Payment of Notes Called for Redemption
Page 35 - SEC and Other Reports
Page 36 - provided
Page 37 - restricted securities
Page 38 - FATCA
Page 39 - Company
Page 40 - Successor Company
Page 41 - Company
Page 42 - N/A
Page 43 - Company s Filing Obligations
Page 44 - Other Remedies
Page 45 - Limitation on Suits
Page 46 - Trustee May File Proofs of Claim.
Page 47 - Duties of Trustee
Page 48 - Rights of Trustee
Page 49 - Individual Rights of Trustee
Page 50 - Compensation and Indemnity
Page 51 - Acceptance by Successor Trustee
Page 52 - Successor Trustee by Merger
Page 53 - Discharge of Liability on Notes
Page 54 - With
Page 55 - Execution of Supplemental Indentures
Page 56 - Interest Make-Whole Payment
Page 57 - Conversion Procedure
Page 58 - provided, however
Page 59 - Individual Holder Beneficial Ownership Limit
Page 60 - Covenants Relating to Underlying Shares
Page 61 - Adjustment for Rights Issue.
Page 62 - Other Distributions.
Page 63 - Spin-Off
Page 64 - Trigger Event
Page 65 - Clause A Distribution
Page 66 - Expiration Date
Page 67 - Holder Participation in Adjustment Events.
Page 68 - provided, however
Page 69 - No Decreases in the Conversion Rate.
Page 70 - Share Exchange Event
Page 71 - Reserved
Page 72 - Trustee
Page 73 - Equity Conditions
Page 74 - Mandatory Conversion Notice
Page 75 - Interest Payment Date
Page 76 - Special Record Date
Page 77 - Call of Meetings by Trustee
Page 78 - provided
Page 79 - Notices
Page 80 - Certificate and Opinion as to Conditions Precedent
Page 81 - Severability Clause
Page 82 - Successors
Page 83 - Withholding Taxes
Page 84 - N/A
Page 85 - EXHIBIT A
Page 86 - N/A
Page 87 - Company,
Page 88 - This Note shall be construed in accordance with and governed by the laws of the State of New York.
Page 89 - N/A
Page 90 - Notes
Page 91 - N/A
Page 92 - N/A
Page 93 - SCHEDULE A6
Page 94 - ATTACHMENT 1
Page 95 - N/A
Page 96 - ATTACHMENT 2
Page 97 - ATTACHMENT 3
Page 98 - N/A
Page 99 - EXHIBIT B
Page 100 - EXHIBIT C